These Regulations may be cited as the Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015.

Regulations 1 and 2 come into force on the day after the day on which these Regulations are made.

Regulations 3 to 7 come into force on 1st October 2015.

In these Regulations—

• “marketing authorisation” has the meaning given by regulation 8(1) of the Human Medicines Regulations 20122;

• “medical device” has the meaning given by regulation 2(1) of the Medical Devices Regulations 20023;

• “medicinal product” has the meaning given by regulation 2(1) of the Human Medicines Regulations 2012;

• “nicotine cartridge” means a cartridge which—

  1. a

     contains a substance which is not tobacco but consists of, or contains, nicotine4, and

  2. b

     is intended to form part of a nicotine inhaling device;

• “nicotine inhaling device” means a device which—

  1. a

     is intended to enable nicotine to be inhaled through a mouth piece (regardless of whether the device is also intended to enable any other substance to be inhaled through a mouth piece), but

  2. b

     is not tobacco, cigarette papers or a device intended to be used for the consumption of lit tobacco;

• “nicotine inhaling product” means a nicotine inhaling device, nicotine cartridge or nicotine refill substance;

• “nicotine refill substance” means a substance which—

  1. a

     is not tobacco but consists of, or contains, nicotine, and

  2. b

     is intended to be used to refill a nicotine inhaling device;

• “parallel import licence” has the meaning given by regulation 48(2) of the Human Medicines Regulations 2012;

• “prescription only medicine” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012.